Michael Muntner

Michael Muntner — Partner, Healthcare Services & Technology, Centerview Partners

Background

• 25+ years in healthcare investment banking; co-founded Centerview's healthcare services & technology practice in 2016.
• Previously 16 years at Credit Suisse as Co-Head of Healthcare, Americas; started his career at Alex. Brown & Sons.
• Advised on $400B+ of transactions, including CVS-Aetna ($78B), Express Scripts-Cigna ($67B), and Oak Street Health-CVS ($11B).

Current focus

• Sits at the center of payor, PBM/specialty pharmacy, distribution, physician services, and healthcare IT/pharma-services deal flow — exactly the CDMO-adjacent corridor of the market.
• Regularly advises both strategics and PE sponsors on large-scale healthcare services M&A.

What he cares about

• Structural shifts in healthcare economics — margin compression, labor cost, and where technology/automation can offset both (a recurring theme in his public commentary).
• Positioning sell-side processes to maximize competitive tension among strategic and sponsor bidders.

Recent moves

• Continues to headline Centerview's healthcare practice; recent public appearance includes the 2025 Pepperdine Graziadio Healthcare Symposium.

Potential sensitivities

• As a sell-side/buy-side advisor, he cannot discuss active mandates or non-public deal specifics — frame outreach around market perspective, not live processes.
• Centerview's client roster is broad; check for conflicts before disclosing target names.

Questions to ask

1. Where is he seeing the most competitive tension right now between strategic acquirers and PE sponsors in pharma services/CDMO?
2. What deal structures or financing terms is he seeing hold up processes in the current healthcare services M&A environment?
3. Which sub-sectors of pharma services does he think are most ripe for consolidation over the next 12-18 months?